Long COVID Monoclonal Antibodies
What are monoclonal antibodies?
Monoclonal antibodies are laboratory-made proteins that act as the body’s naturally
produced antibodies. Monoclonal antibodies supplement antibodies, where they both
travel through the bloodstream to detect and fight foreign substances.
What is the purpose of the study?
The purpose of this study is to determine the safety and effectiveness of monoclonal
antibodies with persistent post-COVID-19 illness, also known as Long Covid (LC), following
an acute infection.
How can I sign up to participate in this study?
You can register for our study using the button below. Once the survey is completed,
you opt-in to being contacted and will receive a call or email from our research staff.
What would I do if I joined the study?
The volunteers of this study will participate in 4 in-person visits at the Davie or
Kendall clinic and 5 virtual visits. During the in-person visits, the injection will
be administered alongside labs being drawn, physical examinations, and online questionnaires.
During virtual visits, you will not need to travel to the NSU campuses. There will
be a telemedicine follow up with online questionnaires during virtual visits. Each
participant is compensated for their time and effort.
What are the eligibility requirements for this study?
- Aged 18-70 years old
- Onset of symptoms occurring on or before August 31st, 2023
- Symptom manifestation meeting the case definition for myalgic encephalomyelitis (ME/CFS).
- Meets the National Academy of Sciences (NAS) criteria for Long COVID
- Any pre-existing illness (like diabetes or hypertension) must be well-controlled and not causing Long COVID symptoms.
How do I unsubscribe from being contacted?
We will not contact or follow-up with you unless you give us permission to do so.
If you receive any further messages from us, please contact us at LongCOVID@nova.edu.
What happens if I do not fill out the survey?
Nothing – It is your choice to participate or not. We will not contact you or follow-up
with you unless you give us permission to do so.
Will I be compensated for participation in this study?
Yes, the participant will get compensated for their time and participation in the
study.
About the Schmidt Initiative for Long Covid
The Schmidt Initiative for Long Covid (SILC) advances clinical care for Long Covid
patients globally. The nonprofit organization, founded in 2023 by philanthropists
Eric and Wendy Schmidt, works to raise the level of Long Covid care and understanding
around the world, connecting specialists and primary care providers to support patients
and share knowledge virtually, in real time. For more information, visit https://silc.org.
Get in Touch
Fort Lauderdale/Davie
Center for Collaborative Research, 4th Floor
7595 SW 33rd Street
Fort Lauderdale, FL 33314
Kendall
Kendall Village Center, Professional Arts Bldg., Suite 111
8501 SW 124th Avenue
Miami, FL 33183
Phone Number: (954) 262-2850
Office Hours: Monday - Friday, 9:00 a.m. - 5:00 p.m.
Connect with INIM on Social
For more information on becoming a donor or joining our newsletter, please email mcarr1@nova.edu.
